BIOAXONE BIOSCIENCES, INC.

Organization

Cambridge, MA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
- Patent number 11,814,361
- Issue date Nov 14, 2023
- BioAxone BioSciences, Inc.
- Kenneth M. Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cerebral cavernous malformations and cerebral aneurysm...
- Patent number 11,701,366
- Issue date Jul 18, 2023
- BioAxone BioSciences, Inc.
- Kenneth M. Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C3 fusion protein and methods of making and using thereof
- Patent number 11,324,802
- Issue date May 10, 2022
- BioAxone BioSciences, Inc.
- Ricardo Borjas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
- Patent number 11,198,680
- Issue date Dec 14, 2021
- BioAxone BioSciences, Inc.
- Kenneth M. Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CNS injury with RNAi therapeutics
- Patent number 11,098,308
- Issue date Aug 24, 2021
- BioAxone BioSciences, Inc.
- Joerg Ruschel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cerebral cavernous malformations and cerebral aneurysm...
- Patent number 10,857,157
- Issue date Dec 8, 2020
- BioAxone BioSciences, Inc.
- Kenneth M. Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Kinase inhibitors for treatment of disease
- Patent number 10,537,567
- Issue date Jan 21, 2020
- BioAxone BioSciences, Inc.
- Joerg Ruschel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
- Patent number 10,526,313
- Issue date Jan 7, 2020
- BioAxone BioSciences, Inc.
- Kenneth M. Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cerebral cavernous malformations and cerebral aneurysm...
- Patent number 10,149,856
- Issue date Dec 11, 2018
- BIOAXONE BIOSCIENCES, INC.
- Kenneth M. Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
- Patent number 10,106,525
- Issue date Oct 23, 2018
- BIOAXONE BIOSCIENCES, INC.
- Kenneth M. Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cerebral cavernous malformations and cerebral aneurysm...
- Patent number 9,687,483
- Issue date Jun 27, 2017
- BIOAXONE BIOSCIENCES, INC.
- Lisa McKerracher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
POLYMORPHS OF SUBSTITUTED ISOQUINOLINE-BASED RHO KINASE INHIBITORS
- Publication number 20230399311
- Publication date Dec 14, 2023
- BioAxone BioSciences, Inc.
- Kenneth M. ROSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C3 FUSION PROTEIN AND METHODS OF MAKING AND USING THEREOF
- Publication number 20220265765
- Publication date Aug 25, 2022
- BioAxone BioSciences, Inc.
- Ricardo BORJAS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICS
- Publication number 20220127617
- Publication date Apr 28, 2022
- BioAxone BioSciences, Inc.
- Joerg RUSCHEL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF
- Publication number 20220089567
- Publication date Mar 24, 2022
- BioAxone BioSciences, Inc.
- Kenneth M. Rosen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSM...
- Publication number 20210290635
- Publication date Sep 23, 2021
- BioAxone BioSciences, Inc.
- Kenneth M. ROSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF
- Publication number 20200199105
- Publication date Jun 25, 2020
- BioAxone BioSciences, Inc.
- Kenneth M. Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICS
- Publication number 20200032268
- Publication date Jan 30, 2020
- BioAxone BioSciences, Inc.
- Joerg RUSCHEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSM...
- Publication number 20190298733
- Publication date Oct 3, 2019
- BioAxone BioSciences, Inc.
- Kenneth M. ROSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KINASE INHIBITORS FOR TREATMENT OF DISEASE
- Publication number 20190015404
- Publication date Jan 17, 2019
- BioAxone BioSciences, Inc.
- Joerg RUSCHEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF
- Publication number 20180297982
- Publication date Oct 18, 2018
- BioAxone BioSciences, Inc.
- Kenneth M. Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF
- Publication number 20170313680
- Publication date Nov 2, 2017
- BioAxone BioSciences, Inc.
- Kenneth M. Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSM...
- Publication number 20170246181
- Publication date Aug 31, 2017
- BioAxone BioSciences, Inc.
- Kenneth M. Rosen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSM...
- Publication number 20160213664
- Publication date Jul 28, 2016
- BioAxone BioSciences, Inc.
- Lisa McKerracher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
87408334 - CETHRIN
- Serial number 87408334
- Filing date Apr 12, 2017
- BioAxone BioSciences Inc.
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 9

Research Projects

Information Research Project
Development of self-delivering RNAi targeted to PTEN for treatment...
- Application id 9564988
- Award notice date Jun 25, 2018
Information Research Project
Development of self-delivering RNAi targeted to PTEN for treatment...
- Application id 9343319
- Award notice date Sep 13, 2017
Information Research Project
Development of BA-1049 for treatment of cerebral cavernous malforma...
- Application id 9352883
- Award notice date Aug 9, 2017
Information Research Project
Development of BA-1049 for treatment of cerebral cavernous malforma...
- Application id 9320314
- Award notice date Sep 14, 2016
Information Research Project
Development of BA-1049 for treatment of cerebral cavernous malforma...
- Application id 9045988
- Award notice date Jan 30, 2016
Information Research Project
Combination of BA-210 and digestion of the glial scar in chronic sp...
- Application id 8832809
- Award notice date Feb 17, 2015
Information Research Project
Regulatory development of PEGylated BA-210 for RGC neuroprotection
- Application id 8890614
- Award notice date Sep 8, 2014
Information Research Project
Development of self-delivering RNAi to evaluate PTEN as a therapeut...
- Application id 8645823
- Award notice date Jul 30, 2014
Information Research Project
Investigation of PEGylated BA-210 for RGC neuroprotection
- Application id 8643711
- Award notice date Mar 20, 2014

BIOAXONE BIOSCIENCES, INC.

Organization

Patents Grantslast 30 patents

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Treatment of cerebral cavernous malformations and cerebral aneurysm...

C3 fusion protein and methods of making and using thereof

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Treatment of CNS injury with RNAi therapeutics

Treatment of cerebral cavernous malformations and cerebral aneurysm...

Kinase inhibitors for treatment of disease

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Treatment of cerebral cavernous malformations and cerebral aneurysm...

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Treatment of cerebral cavernous malformations and cerebral aneurysm...

Patents Applicationslast 30 patents

POLYMORPHS OF SUBSTITUTED ISOQUINOLINE-BASED RHO KINASE INHIBITORS

C3 FUSION PROTEIN AND METHODS OF MAKING AND USING THEREOF

TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICS

RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF

TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSM...

RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF

TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICS

TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSM...

KINASE INHIBITORS FOR TREATMENT OF DISEASE

RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF

RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF

TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSM...

TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSM...

Trademarklast 30 trademarks

87408334 - CETHRIN

NIH Research Projectlast 12 months

Research Projects

Development of self-delivering RNAi targeted to PTEN for treatment...

Development of self-delivering RNAi targeted to PTEN for treatment...

Development of BA-1049 for treatment of cerebral cavernous malforma...

Development of BA-1049 for treatment of cerebral cavernous malforma...

Development of BA-1049 for treatment of cerebral cavernous malforma...

Combination of BA-210 and digestion of the glial scar in chronic sp...

Regulatory development of PEGylated BA-210 for RGC neuroprotection

Development of self-delivering RNAi to evaluate PTEN as a therapeut...

Investigation of PEGylated BA-210 for RGC neuroprotection